$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Downregulation of CR6-interacting factor 1 suppresses keloid fibroblast growth via the TGF-β/Smad signaling pathway 원문보기

Scientific reports, v.11 no.1, 2021년, pp.500 -   

Nagar, Harsha (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) ,  Kim, Sungmin (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) ,  Lee, Ikjun (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) ,  Kim, Seonhee (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) ,  Choi, Su-Jeong (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) ,  Piao, Shuyu (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) ,  Jeon, Byeong Hwa (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea) ,  Oh, Sang-Ha (Department of Plastic and Reconstructive Surgery, School of Medicine, Chungnam National University, 282 Munhwa-ro, Jung-Gu, Daejeon, 35015 Republic of Korea) ,  Kim, Cuk-Seong (Department of Medical Science, Chungnam National University, Daejeon, Republic of Korea)

Abstract AI-Helper 아이콘AI-Helper

Keloids are a type of aberrant skin scarring characterized by excessive accumulation of collagen and extracellular matrix (ECM), arising from uncontrolled wound healing responses. While typically non-pathogenic, keloids are occasionally regarded as a form of benign tumor. CR6-interacting factor 1 (C...

참고문헌 (39)

  1. 1. Li S Liu W Lei Y Long J Regulatory effects of electronic beam irradiation on mir-21/smad7-mediated collagen I synthesis in keloid-derived fibroblasts Biol. Open 2016 5 1567 1574 10.1242/bio.018770 27694104 

  2. 2. Dong X Zhang C Ma S Wen H Mast cell chymase in keloid induces profibrotic response via transforming growth factor-beta1/Smad activation in keloid fibroblasts Int. J. Clin. Exp. Pathol. 2014 7 3596 3607 25120737 

  3. 3. Butler PD Longaker MT Yang GP Current progress in keloid research and treatment J. Am. Coll. Surg. 2008 206 731 741 10.1016/j.jamcollsurg.2007.12.001 18387480 

  4. 4. Seifert O Mrowietz U Keloid scarring: Bench and bedside Arch. Dermatol. Res. 2009 301 259 272 10.1007/s00403-009-0952-8 19360429 

  5. 5. Shih B Garside E McGrouther DA Bayat A Molecular dissection of abnormal wound healing processes resulting in keloid disease Wound Repair Regen. 2010 18 139 153 10.1111/j.1524-475X.2009.00553.x 20002895 

  6. 6. Sandulache VC Parekh A Li-Korotky H Dohar JE Hebda PA Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta1-induced collagen synthesis Wound Repair Regen. 2007 15 122 133 10.1111/j.1524-475X.2006.00193.x 17244328 

  7. 7. Xia W Longaker MT Yang GP P38 MAP kinase mediates transforming growth factor-beta2 transcription in human keloid fibroblasts Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006 290 R501 R508 10.1152/ajpregu.00472.2005 16467496 

  8. 8. Chin GS Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts Plast. Reconstr. Surg. 2001 108 423 429 10.1097/00006534-200108000-00022 11496185 

  9. 9. Berman B Maderal A Raphael B Keloids and hypertrophic scars: Pathophysiology, classification, and treatment Dermatol. Surg. 2017 43 Suppl 1 S3 S18 10.1097/DSS.0000000000000819 27347634 

  10. 10. Chung HK CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle J. Biol. Chem. 2003 278 28079 28088 10.1074/jbc.M212835200 12716909 

  11. 11. Park KC CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation Mol. Endocrinol. 2005 19 12 24 10.1210/me.2004-0107 15459248 

  12. 12. Kwon MC Crif1 is a novel transcriptional coactivator of STAT3 EMBO J. 2008 27 642 653 10.1038/sj.emboj.7601986 18200042 

  13. 13. Kim SJ CRIF1 is essential for the synthesis and insertion of oxidative phosphorylation polypeptides in the mammalian mitochondrial membrane Cell Metab. 2012 16 274 283 10.1016/j.cmet.2012.06.012 22819524 

  14. 14. Nagar H CR6-interacting factor 1 deficiency impairs vascular function by inhibiting the Sirt1-endothelial nitric oxide synthase pathway Antioxid. Redox Signal 2017 27 234 249 10.1089/ars.2016.6719 28117598 

  15. 15. Vincent AS Human skin keloid fibroblasts display bioenergetics of cancer cells J. Investig. Dermatol. 2008 128 702 709 10.1038/sj.jid.5701107 17943178 

  16. 16. Russell SB Trupin KM Rodriguez-Eaton S Russell JD Trupin JS Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth Proc. Natl. Acad. Sci. U.S.A. 1988 85 587 591 10.1073/pnas.85.2.587 3422443 

  17. 17. Witt E Maliri A McGrouther DA Bayat A RAC activity in keloid disease: Comparative analysis of fibroblasts from margin of keloid to its surrounding normal skin Eplasty 2008 8 e19 18463712 

  18. 18. Al-Attar A Mess S Thomassen JM Kauffman CL Davison SP Keloid pathogenesis and treatment Plast. Reconstr. Surg. 2006 117 286 300 10.1097/01.prs.0000195073.73580.46 16404281 

  19. 19. Bock O Mrowietz U Keloids. A fibroproliferative disorder of unknown etiology Hautarzt 2002 53 515 523 10.1007/s00105-001-0316-6 12221465 

  20. 20. Satish L Babu M Tran KT Hebda PA Wells A Keloid fibroblast responsiveness to epidermal growth factor and activation of downstream intracellular signaling pathways Wound Repair Regen. 2004 12 183 192 10.1111/j.1067-1927.2004.012111.x 15086770 

  21. 21. Fujiwara M Muragaki Y Ooshima A Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration Br. J. Dermatol. 2005 153 295 300 10.1111/j.1365-2133.2005.06698.x 16086739 

  22. 22. Nedelec B Shankowsky H Scott PG Ghahary A Tredget EE Myofibroblasts and apoptosis in human hypertrophic scars: The effect of interferon-alpha2b Surgery 2001 130 798 808 10.1067/msy.2001.116453 11685189 

  23. 23. Dong X Mao S Wen H Upregulation of proinflammatory genes in skin lesions may be the cause of keloid formation (review) Biomed. Rep. 2013 1 833 836 10.3892/br.2013.169 24649037 

  24. 24. Vyas S Zaganjor E Haigis MC Mitochondria and cancer Cell 2016 166 555 566 10.1016/j.cell.2016.07.002 27471965 

  25. 25. Attisano L Wrana JL Signal transduction by the TGF-beta superfamily Science 2002 296 1646 1647 10.1126/science.1071809 12040180 

  26. 26. Inman GJ Linking Smads and transcriptional activation Biochem. J. 2005 386 e1 e3 10.1042/BJ20042133 15702493 

  27. 27. Hayashi H The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling Cell 1997 89 1165 1173 10.1016/S0092-8674(00)80303-7 9215638 

  28. 28. Nakao A Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling Nature 1997 389 631 635 10.1038/39369 9335507 

  29. 29. Briones-Orta MA Tecalco-Cruz AC Sosa-Garrocho M Caligaris C Macias-Silva M Inhibitory Smad7: Emerging roles in health and disease Curr. Mol. Pharmacol. 2011 4 141 153 10.2174/1874467211104020141 21222648 

  30. 30. Yu H Bock O Bayat A Ferguson MW Mrowietz U Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring J. Plast. Reconstr. Aesthet. Surg. 2006 59 221 229 10.1016/j.bjps.2005.06.010 16676428 

  31. 31. Zhou R Wang C Wen C Wang D miR-21 promotes collagen production in keloid via Smad7 Burns 2017 43 555 561 10.1016/j.burns.2016.09.013 27717618 

  32. 32. Gandhi NS Tekade RK Chougule MB Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances J. Control Release 2014 194 238 256 10.1016/j.jconrel.2014.09.001 25204288 

  33. 33. Pauley KM Cha S RNAi therapeutics in autoimmune disease Pharmaceuticals (Basel) 2013 6 287 294 10.3390/ph6030287 24276020 

  34. 34. Khavari PA Rollman O Vahlquist A Cutaneous gene transfer for skin and systemic diseases J. Intern. Med. 2002 252 1 10 10.1046/j.1365-2796.2002.00995.x 12074732 

  35. 35. Aldawsari M Chougule MB Babu RJ Progress in topical siRNA delivery approaches for skin disorders Curr. Pharm. Des. 2015 21 4594 4605 10.2174/1381612821666150911093606 26362644 

  36. 36. Chen M Topical delivery of siRNA into skin using SPACE-peptide carriers J. Control Release 2014 179 33 41 10.1016/j.jconrel.2014.01.006 24434423 

  37. 37. Liang X Skin delivery of siRNA using sponge spicules in combination with cationic flexible liposomes Mol. Ther. Nucleic Acids 2020 20 639 648 10.1016/j.omtn.2020.04.003 32380414 

  38. 38. Marttala J Andrews JP Rosenbloom J Uitto J Keloids: Animal models and pathologic equivalents to study tissue fibrosis Matrix Biol. 2016 51 47 54 10.1016/j.matbio.2016.01.014 26827712 

  39. 39. Seo BF Lee JY Jung SN Models of abnormal scarring Biomed. Res. Int. 2013 2013 423147 10.1155/2013/423147 24078916 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로